Home » FDA Cancels Advisory Panel on Lilly Drug Cymbalta
FDA Cancels Advisory Panel on Lilly Drug Cymbalta
The Food and Drug Administration has canceled an advisory panel meeting involving Eli
Lilly & Co.’s antidepressant Cymbalta.
CNNMoney
CNNMoney
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May